| 1 |
18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial
Jérémie Calais et al. · The Lancet Oncology
Open access |
30 Jul 2019 |
477 |
| 2 |
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
Francesco Ceci, Daniela E. Oprea‐Lager, Louise Emmett et al. · European Journal of Nuclear Medicine and Molecular Imaging
Open access |
19 Feb 2021 |
372 |
| 3 |
A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)
Luca Valle, Eric J. Lehrer, Daniela Markovic et al. · European Urology
ReviewOpen access |
11 Dec 2020 |
317 |
| 4 |
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
Clemens Kratochwil et al. · European Journal of Nuclear Medicine and Molecular Imaging
Open access |
29 May 2023 |
299 |
| 5 |
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
Mark M. Souweidane, Kim Kramer, Neeta Pandit‐Taskar et al. · The Lancet Oncology
Open access |
18 Jun 2018 |
274 |
| 6 |
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study
Andrei Gafita et al. · The Lancet Oncology
Open access |
8 Jul 2021 |
267 |
| 7 |
Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications
Venkatesh Katari, Shounak K. Ghosh, Madhubanti Mullick et al. · Cell and Tissue Research
|
7 May 2019 |
255 |
| 8 |
Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients
Frederik Lars Giesel, Clemens Kratochwil, Joel Schlittenhardt et al. · European Journal of Nuclear Medicine and Molecular Imaging
Open access |
17 Jun 2021 |
229 |
| 9 |
[89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial
Brian M. Shuch et al. · The Lancet Oncology
Open access |
10 Sep 2024 |
150 |
| 10 |
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study
Andrei Gafita, Isabel Rauscher, Manuel Weber et al. · Journal of Nuclear Medicine
Open access |
14 Apr 2022 |
141 |
| 11 |
Impact of 68 Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
Ida Sonni, Matthias Eiber, Wolfgang P. Fendler et al. · Journal of Nuclear Medicine
Open access |
10 Jan 2020 |
141 |
| 12 |
Nanoparticles for the treatment of liver fibrosis
Suchithra Poilil Surendran, Reju George Thomas, Myeong-Ju Moon et al. · International Journal of Nanomedicine
Open access |
Sep 2017 |
140 |
| 13 |
Head-to-Head Comparison of 68 Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial
Ida Sonni, Ely Richard Felker, Andrew Thomas Lenis et al. · Journal of Nuclear Medicine
Open access |
14 Oct 2021 |
136 |
| 14 |
Roadmap on optical sensors
Mário F. S. Ferreira, Enrique Castro-Camus, David J. Ottaway et al. · Journal of Optics
Open access |
24 Jul 2017 |
135 |
| 15 |
High‐fidelity detection and sorting of nanoscale vesicles in viral disease and cancer
Aizea Morales‐Kastresana et al. · Journal of Extracellular Vesicles
Open access |
19 Jun 2019 |
133 |
| 16 |
The Noscapine Chronicle: A Pharmaco‐Historic Biography of the Opiate Alkaloid Family and its Clinical Applications
Padmashree C.G. Rida, Dillon LiVecche, Angela Ogden et al. · Medicinal Research Reviews
Open access |
14 Jul 2015 |
130 |
| 17 |
Infrared spectral histopathology (SHP): a novel diagnostic tool for the accurate classification of lung cancer
Benjamin Bird, Miloš D. Miljković, Stan H Remiszewski et al. · Laboratory Investigation
Open access |
2 Jul 2012 |
127 |
| 18 |
Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer
Karuna Mittal, Shashi Donthamsetty, Ramneet Kaur et al. · British Journal of Cancer
Open access |
23 Mar 2017 |
123 |
| 19 |
FAP: The Next Billion Dollar Nuclear Theranostics Target?
Jérémie Calais · Journal of Nuclear Medicine
Open access |
10 Jan 2020 |
122 |
| 20 |
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer
Andrei Gafita, Loïc Djaileb, Isabel Rauscher et al. · Radiology
Open access |
Jul 2023 |
116 |
| 21 |
Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
Jérémie Calais, Johannes G. Czernin, Wolfgang P. Fendler et al. · BMC Cancer
Open access |
7 Jan 2019 |
113 |
| 22 |
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Sarah Marie Larson et al. · Cancer Discovery
Open access |
23 Nov 2022 |
105 |
| 23 |
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
Andrei Gafita, Isabel Rauscher, Wolfgang P. Fendler et al. · European Journal of Nuclear Medicine and Molecular Imaging
|
29 Jun 2022 |
104 |
| 24 |
Non-oncologic incidental uptake on FAPI PET/CT imaging
Masatoshi Hotta, Angela Castellanos Rieger, Mahbod G Jafarvand et al. · British Journal of Radiology
Open access |
Jul 2022 |
103 |
| 25 |
Clinical guideline for the diagnosis and treatment of cutaneous warts (2022)
Peiyao Zhu et al. · Journal of Evidence-Based Medicine
Open access |
Sep 2022 |
101 |
| 26 |
68Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership
Giuseppe Carlucci, Robin Ippisch, Roger Slavik et al. · Journal of Nuclear Medicine
Open access |
18 Dec 2020 |
98 |
| 27 |
Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152 Tb-DOTATOC
Richard Paul Baum, Aviral Singh, Martina Benešová et al. · Dalton Transactions
Open access |
2017 |
91 |
| 28 |
Improving the Quality of Synthetic FLAIR Images with Deep Learning Using a Conditional Generative Adversarial Network for Pixel-by-Pixel Image Translation
Akifumi Hagiwara, Yujiro Otsuka, Masaaki Hori et al. · American Journal of Neuroradiology
Open access |
10 Jan 2019 |
90 |
| 29 |
Prostate-specific Membrane Antigen PET in Prostate Cancer
Courtney A. Lawhn-Heath, Ali Salavati, Spencer C. Behr et al. · Radiology
|
30 Mar 2021 |
89 |
| 30 |
Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality?
Andrei Gafita et al. · Journal of Nuclear Medicine
Open access |
28 May 2021 |
88 |
| 31 |
Conductive polymer‐carbon black composites‐based sensor arrays for use in an electronic nose
Beth C. Muñoz, Gregory Steinthal, Steven A. Sunshine · Sensor Review
|
Dec 1999 |
79 |
| 32 |
The Future of Nuclear Medicine as an Independent Specialty
Johannes G. Czernin, Ida Sonni, Aria A. Razmaria et al. · Journal of Nuclear Medicine
Open access |
Sep 2019 |
75 |
| 33 |
Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer
Zheng‐Rong Lu, Victoria E. A. Laney, Yajuan Li · Accounts of Chemical Research
|
19 Sep 2022 |
73 |
| 34 |
PSMA-targeted Radiotracers versus 18F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis
Nelly Tan, Udochukwu E. Oyoyo, Niusha Bavadian et al. · Radiology
Review |
12 May 2020 |
72 |
| 35 |
Application of Combination High‐Throughput Phenotypic Screening and Target Identification Methods for the Discovery of Natural Product‐Based Combination Drugs
Monica Isgut, Rao Mukkavilli, Chunhua Yang et al. · Medicinal Research Reviews
|
16 May 2017 |
70 |
| 36 |
SNMMI Procedure Standard/EANM Practice Guideline for Fibroblast Activation Protein (FAP) PET
Thomas A. Hope, Jérémie Calais, Ajit Harishkumar Goenka et al. · Journal of Nuclear Medicine
Open access |
21 Nov 2024 |
63 |
| 37 |
Outcome of Patients with PSMA PET/CT Screen Failure by VISION Criteria and Treated with 177Lu-PSMA Therapy: A Multicenter Retrospective Analysis
Masatoshi Hotta, Andrei Gafita, Johannes G. Czernin et al. · Journal of Nuclear Medicine
Open access |
10 Mar 2022 |
63 |
| 38 |
Salvage therapy for prostate cancer after radical prostatectomy
Nicholas George Zaorsky, Jérémie Calais, Stefano Fanti et al. · Nature Reviews Urology
Review |
6 Aug 2021 |
62 |
| 39 |
A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas
Karuna Mittal, Da Hoon Choi, Sergey Klimov et al. · Journal of Ovarian Research
Open access |
18 Mar 2016 |
61 |
| 40 |
Dosimetry of [177Lu]Lu-PSMA–Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis
Zachary Ells, Tristan Grogan, Johannes G. Czernin et al. · Journal of Nuclear Medicine
ReviewOpen access |
3 Jul 2024 |
59 |
| 41 |
Classification of malignant and benign tumors of the lung by infrared spectral histopathology (SHP)
Ali Akalin, Xinying Mu, Mark Kon et al. · Laboratory Investigation
Open access |
9 Feb 2015 |
58 |
| 42 |
PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [ 177 Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
Masatoshi Hotta, Andrei Gafita, Vishnu Murthy et al. · Journal of Nuclear Medicine
Open access |
30 Mar 2023 |
55 |
| 43 |
Will FAPI PET/CT Replace FDG PET/CT in the Next Decade? Point—An Important Diagnostic, Phenotypic, and Biomarker Role
Jérémie Calais, Christine E. Mona · American Journal of Roentgenology
|
29 Jul 2020 |
54 |
| 44 |
Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial
Adrien Holzgreve, Marcus Unterrainer, Jérémie Calais et al. · European Journal of Nuclear Medicine and Molecular Imaging
Open access |
10 Jul 2023 |
51 |
| 45 |
Total-Body 68Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan Guidelines
Kelsey L. Pomykala, Johannes G. Czernin, Tristan Grogan et al. · Journal of Nuclear Medicine
Open access |
20 Sep 2019 |
51 |
| 46 |
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
Jérémie Calais et al. · Journal of Nuclear Medicine
Open access |
20 May 2021 |
50 |
| 47 |
Influence of CuO nanoparticles and graphene nanoplatelets on the sensing behaviour of poly(vinyl alcohol) nanocomposites for the detection of ethanol and propanol vapors
G.J. Thangamani, Kalim Deshmukh, Kannan Chidambaram et al. · Journal of Materials Science Materials in Electronics
|
11 Jan 2018 |
49 |
| 48 |
Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI
Zheng Han, Yajuan Li, Sarah M. Roelle et al. · Bioconjugate Chemistry
Open access |
16 Feb 2017 |
49 |
| 49 |
Intramyocardial hemorrhage drives fatty degeneration of infarcted myocardium
Ivan Cokic et al. · Nature Communications
Open access |
27 Oct 2022 |
47 |
| 50 |
Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors
Bin Ji, Hiroyuki Kaneko, Takafumi Minamimoto et al. · Journal of Neuroscience
Open access |
9 Nov 2016 |
46 |